SEBI Debarred Entities
The SEBI debarred entities list includes individuals and organizations that have been prohibited by the securities and exchange board of India (SEBI) from participating in securities markets. This action is typically taken due to violations of regulatory guidelines or laws related to securities trading and investment.
Mitigate risk with our comprehensive screening solutions for your AML and sanctions compliance.
11,559 Entities in SEBI Debarred Entities
| Entity Name | Entity Type | Effective Date | Status |
|---|---|---|---|
Shree satyanarayan investments co ltd | Company | May 20, 2015 | active |
Miker financial consultants pvt ltd | Company | May 30, 2024 | inactive |
Mega mould india limited | Company | Jul 24, 2014 | inactive |
Mega mould india limited | Company | Mar 5, 2015 | active |
Noel agritech limited | Company | Oct 21, 2016 | inactive |
Tria fine chem ltd | Company | May 15, 2014 | active |
Tria fine chem ltd | Company | May 15, 2014 | inactive |
Elm park fund limited | Company | Aug 7, 2017 | active |
Bharat global developers limited | Company | Dec 23, 2024 | active |
Bharat global developers limited | Company | Dec 23, 2024 | active |
FAQs
Why is compliance with the Sanctioned Providers by The Defense Health Agency of United States (DHA) necessary?
Compliance with the Sanctioned Providers List published by the Defense Health Agency (DHA) is crucial for maintaining the integrity and security of healthcare services. These sanctions are implemented to protect beneficiaries from entities that may engage in fraudulent or unsafe practices. Adherence ensures that healthcare providers are not only meeting legal and regulatory standards but also safeguarding public health. Failing to comply can result in serious legal implications, financial penalties, and a diminished quality of care for those who rely on DHA services.
Which companies should comply with Sanctioned Providers by The Defense Health Agency of United States (DHA)?
The Sanctioned Providers List by the Defense Health Agency (DHA) primarily impacts healthcare organizations, including hospitals, clinics, and pharmaceutical companies. These entities must comply to ensure they do not engage with individuals or organizations that pose risks to patient safety or violate federal regulations. Compliance protects public health and maintains the integrity of the healthcare system while avoiding legal repercussions.
APIs
Data License
Solutions
Pricing
All rights reserved | Terms of use Copyright ©2025 Trademo Technologies Inc.